Total Payments
$8,592
2024 Payments
$1,166
Companies
57
Transactions
363
Medicare Patients
8,459
Medicare Billing
$1.2M
Payment Breakdown by Category
Food & Beverage$8,451 (98.4%)
Education$141.28 (1.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,451 | 358 | 98.4% |
| Education | $141.28 | 5 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $1,003 | 58 | $0 (2024) |
| ABBVIE INC. | $890.81 | 35 | $0 (2024) |
| Astellas Pharma US Inc | $665.80 | 31 | $0 (2024) |
| PFIZER INC. | $568.01 | 22 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $396.04 | 20 | $0 (2024) |
| UROGEN PHARMA, INC. | $360.99 | 14 | $0 (2024) |
| Allergan, Inc. | $336.26 | 13 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $282.37 | 6 | $0 (2023) |
| NxThera, Inc. | $281.92 | 3 | $0 (2018) |
| Amgen Inc. | $248.26 | 10 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,166 | 46 | PFIZER INC. ($173.90) |
| 2023 | $1,695 | 72 | Sumitomo Pharma America, Inc. ($245.81) |
| 2022 | $1,249 | 55 | Astellas Pharma US Inc ($191.41) |
| 2021 | $677.69 | 36 | UROVANT SCIENCES INC ($110.69) |
| 2020 | $685.71 | 34 | Astellas Pharma US Inc ($93.75) |
| 2019 | $797.60 | 40 | Janssen Biotech, Inc. ($179.51) |
| 2018 | $1,135 | 44 | Janssen Biotech, Inc. ($333.47) |
| 2017 | $1,187 | 36 | Allergan Inc. ($165.43) |
All Payment Transactions
363 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | COLOPLAST CORP | — | Food and Beverage | In-kind items and services | $17.27 | General |
| 12/12/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: UROLOGY | ||||||
| 12/11/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $27.11 | General |
| Category: Oncology | ||||||
| 12/11/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/05/2024 | Boston Scientific Corporation | SpaceOAR System (Device) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Space OAR_URO | ||||||
| 11/27/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.02 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/08/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $16.48 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
| 11/05/2024 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $33.82 | General |
| 11/05/2024 | KARL STORZ Endoscopy-America | n.a. (Device) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: UROLOGY | ||||||
| 10/16/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: ONCOLOGY | ||||||
| 10/11/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $52.26 | General |
| Category: HORMONE THERAPY | ||||||
| 10/11/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $1.96 | General |
| Category: HORMONE THERAPY | ||||||
| 10/04/2024 | IMMUNITYBIO, INC. | ANKTIVA (Drug) | Food and Beverage | In-kind items and services | $34.97 | General |
| Category: Immunotherapy | ||||||
| 09/30/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/25/2024 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $52.23 | General |
| 09/05/2024 | Merck Sharp & Dohme LLC | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/27/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA, BALVERSA | Food and Beverage | In-kind items and services | $29.52 | General |
| Category: Oncology | ||||||
| 08/23/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Oncology | ||||||
| 08/23/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $9.61 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/22/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: HORMONE THERAPY | ||||||
| 08/22/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $0.89 | General |
| Category: HORMONE THERAPY | ||||||
| 08/01/2024 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: ONCOLOGY | ||||||
| 07/23/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: UROLOGY | ||||||
| 07/12/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: ONCOLOGY | ||||||
| 07/11/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $31.52 | General |
| Category: UROTHELIAL CANCER | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 2,045 | 11,310 | $1.1M | $263,271 |
| 2022 | 33 | 2,087 | 9,180 | $1.4M | $316,058 |
| 2021 | 31 | 2,253 | 7,798 | $1.2M | $328,741 |
| 2020 | 31 | 2,074 | 10,592 | $1.0M | $315,101 |
Total Patients
8,459
Total Services
38,880
Medicare Billing
$1.2M
Procedure Codes
129
All Medicare Procedures & Services
129 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 429 | 573 | $174,765 | $62,584 | 35.8% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 93 | 120 | $75,600 | $27,116 | 35.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 267 | 300 | $63,000 | $22,333 | 35.4% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 17 | 147 | $309,656 | $20,058 | 6.5% |
| 64566 | Insertion of lower leg neurostimulator electrode | Office | 2023 | 78 | 160 | $72,320 | $19,216 | 26.6% |
| J9030 | Bcg live intravesical instillation, 1 mg | Office | 2023 | 31 | 8,400 | $54,600 | $18,623 | 34.1% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 33 | 180 | $62,280 | $15,480 | 24.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 102 | 102 | $47,022 | $14,194 | 30.2% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2023 | 15 | 15 | $34,610 | $8,537 | 24.7% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2023 | 22 | 22 | $20,526 | $7,963 | 38.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 40 | 47 | $19,082 | $6,714 | 35.2% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2023 | 23 | 23 | $13,478 | $4,774 | 35.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 41 | 41 | $16,892 | $4,733 | 28.0% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 43 | 62 | $16,864 | $4,670 | 27.7% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 17 | 17 | $12,189 | $4,114 | 33.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 21 | 21 | $12,285 | $3,248 | 26.4% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 27 | 44 | $11,176 | $2,539 | 22.7% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 17 | 17 | $7,514 | $2,498 | 33.2% |
| 76857 | Limited ultrasound scan of pelvis | Office | 2023 | 48 | 48 | $15,456 | $2,142 | 13.9% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 17 | 19 | $29,292 | $2,078 | 7.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 19 | 19 | $5,852 | $1,690 | 28.9% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 113 | 124 | $8,060 | $1,322 | 16.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 288 | 530 | $8,480 | $1,166 | 13.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 12 | 15 | $3,330 | $1,077 | 32.3% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 82 | 85 | $19,890 | $985.36 | 5.0% |
About Dr. Jesse Le, M.D
Dr. Jesse Le, M.D is a Urology healthcare provider based in Concord, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2010. The National Provider Identifier (NPI) number assigned to this provider is 1457679201.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jesse Le, M.D has received a total of $8,592 in payments from pharmaceutical and medical device companies, with $1,166 received in 2024. These payments were reported across 363 transactions from 57 companies. The most common payment nature is "Food and Beverage" ($8,451).
As a Medicare-enrolled provider, Le has provided services to 8,459 Medicare beneficiaries, totaling 38,880 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 129 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Concord, CA
- Active Since 05/04/2010
- Last Updated 06/08/2018
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1457679201
Products in Payments
- XTANDI (Drug) $713.38
- ORGOVYX (Drug) $495.85
- ERLEADA (Drug) $433.82
- GEMTESA (Drug) $385.71
- BOTOX (Biological) $361.62
- JELMYTO (Drug) $360.99
- LUPRON DEPOT (Drug) $342.17
- ZYTIGA (Drug) $316.31
- Rezum (Device) $281.92
- Erleada (Drug) $261.35
- Myrbetriq (Drug) $216.68
- Lupron (Drug) $189.89
- Dornier MedTech (Device) $173.94
- AVEED (Biological) $169.28
- BOTOX OAB (Drug) $165.43
- Nubeqa (Drug) $161.93
- LYNPARZA (Drug) $157.42
- Prolia (Biological) $146.84
- Lupron Depot (Drug) $130.27
- IMFINZI (Drug) $124.95
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Concord
Dr. Richard Natale, Md, MD
Urology — Payments: $112,496
Urology $112,496
Ramiro Madden-Fuentes, Md, MD
Urology — Payments: $68,069
Urology $68,069
Tom Floyd, M.d, M.D
Urology — Payments: $13,455
Urology $13,455
Dr. Wei Zheng, M.d, M.D
Urology — Payments: $11,601
Urology $11,601
Jeremy Lieb, M.d, M.D
Urology — Payments: $5,924
Urology $5,924
Dr. Judson Brandeis, M.d, M.D
Urology — Payments: $4,636
Urology $4,636